Cappello Joseph 4
4 · GENELUX Corp · Filed Dec 18, 2024
Insider Transaction Report
Form 4
GENELUX CorpGNLX
Cappello Joseph
VP, Pharmaceutical Development
Transactions
- Sale
Common Stock
2024-12-16$2.34/sh−6,300$14,742→ 14,653 total
Footnotes (1)
- [F1]Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units.